Cardiovascular composition

Details Cardiovascular composition Cardiovascular composition

A - Human Necessities

61

K

167/192, 167/290

A61K 31/045 (2006.01) A61K 31/705 (1985.01)

Patent

CA 1266236

ABSTRACT OF THE DISCLOSURE A new pharmaceutical composition for treatment and prevention of cardiovascular disease, and increasing immune function contains Ginsenoside, Ophiopogonin, Sesquicarene and Chamigrene. Processed for producing these components and the composition, referred to as Pure San-Mai-Sen (PSMS), are provided. - 18 -

508064

Affiliated with

Also associated with

Rating

Cardiovascular composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cardiovascular composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiovascular composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1180926